118 related articles for article (PubMed ID: 38388240)
1. Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020.
Lloyd PC; Lufkin B; Moll K; Ogilvie RP; McMahill-Walraven CN; Beachler DC; Kelman JA; Shi X; Hobbi S; Amend KL; Djibo DA; Shangguan S; Shoaibi A; Sheng M; Secora A; Zhou CK; Kowarski L; Chillarige Y; Forshee RA; Anderson SA; Muthuri S; Seeger JD; Kline A; Reich C; MaCurdy T; Wong HL
Vaccine; 2024 Mar; 42(8):2004-2010. PubMed ID: 38388240
[TBL] [Abstract][Full Text] [Related]
2. Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020.
Moll K; Lufkin B; Fingar KR; Ke Zhou C; Tworkoski E; Shi C; Hobbi S; Hu M; Sheng M; McCarty J; Shangguan S; Burrell T; Chillarige Y; Beers J; Saunders-Hastings P; Muthuri S; Edwards K; Black S; Kelman J; Reich C; Amend KL; Djibo DA; Beachler D; Ogilvie RP; Secora A; McMahill-Walraven CN; Seeger JD; Lloyd P; Thompson D; Dimova R; MaCurdy T; Obidi J; Anderson S; Forshee R; Wong HL; Shoaibi A
Vaccine; 2023 Jan; 41(2):333-353. PubMed ID: 36404170
[TBL] [Abstract][Full Text] [Related]
3. Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.
See I; Lale A; Marquez P; Streiff MB; Wheeler AP; Tepper NK; Woo EJ; Broder KR; Edwards KM; Gallego R; Geller AI; Jackson KA; Sharma S; Talaat KR; Walter EB; Akpan IJ; Ortel TL; Urrutia VC; Walker SC; Yui JC; Shimabukuro TT; Mba-Jonas A; Su JR; Shay DK
Ann Intern Med; 2022 Apr; 175(4):513-522. PubMed ID: 35038274
[TBL] [Abstract][Full Text] [Related]
4. Background rate estimations for thrombosis with thrombocytopaenia: challenges in evaluating rare safety signals following vaccination in real time during a pandemic.
Müllerová H; Medin J; Arnold M; Gomes da Silva H; Kumar S; Nord M; Hubbard R; de Lusignan S
BMJ Open; 2023 Jan; 13(1):e063645. PubMed ID: 36639216
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis with thrombocytopenia syndrome: A database review of clinical trial and post-marketing experience with Ad26.COV2.S.
Struyf F; Hardt K; Van Rampelbergh R; Shukarev G; Inamdar A; Ruiz-Guiñazú J; van Paassen V; Anaya-Velarde L; Diba C; Ceuppens M; Cardenas V; Soff GA; Pragalos A; Sadoff J; Douoguih M
Vaccine; 2023 Aug; 41(37):5351-5359. PubMed ID: 37517912
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.
Lai CC; Ko WC; Chen CJ; Chen PY; Huang YC; Lee PI; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1027-1035. PubMed ID: 34176415
[TBL] [Abstract][Full Text] [Related]
7. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.
Li X; Ostropolets A; Makadia R; Shoaibi A; Rao G; Sena AG; Martinez-Hernandez E; Delmestri A; Verhamme K; Rijnbeek PR; Duarte-Salles T; Suchard MA; Ryan PB; Hripcsak G; Prieto-Alhambra D
BMJ; 2021 Jun; 373():n1435. PubMed ID: 35727911
[TBL] [Abstract][Full Text] [Related]
8. Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England.
Whiteley WN; Ip S; Cooper JA; Bolton T; Keene S; Walker V; Denholm R; Akbari A; Omigie E; Hollings S; Di Angelantonio E; Denaxas S; Wood A; Sterne JAC; Sudlow C;
PLoS Med; 2022 Feb; 19(2):e1003926. PubMed ID: 35192597
[TBL] [Abstract][Full Text] [Related]
9. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
MacIntyre CR; Veness B; Berger D; Hamad N; Bari N
Vaccine; 2021 Aug; 39(34):4784-4787. PubMed ID: 34272095
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations.
Laffan MA; Rees S; Yadavalli M; Ferstenberg LB; Kumar Shankar N; Medin J; Foskett N; Arnold M; Gomes da Silva H; Bhuyan P; Nord M
Vaccine; 2022 Sep; 40(38):5585-5593. PubMed ID: 35989136
[TBL] [Abstract][Full Text] [Related]
11. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
MacNeil JR; Su JR; Broder KR; Guh AY; Gargano JW; Wallace M; Hadler SC; Scobie HM; Blain AE; Moulia D; Daley MF; McNally VV; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):651-656. PubMed ID: 33914723
[TBL] [Abstract][Full Text] [Related]
12. The incidence of thrombosis with co-occurring thrombocytopenia prior to the SARS-CoV2 pandemic: A population-based study.
Liu Y; Goh CH; Shen D; Qiu H; Huang KC; Luo M; Chen Z; Tang CH
PLoS One; 2024; 19(5):e0301359. PubMed ID: 38787838
[TBL] [Abstract][Full Text] [Related]
13. Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A cross-sectional study in six EU member states.
Buhl C; Jacobsen R; Almarsdóttir AB; Abtahi S; Andersen A; Deligianni E; Dermiki-Gkana F; Kontogiorgis C; Oikonomou C; Kursite M; Poplavska E; Hegger I; van der Goot M; Sousa Ferreira PB; Ribeiro-Vaz I; Silva AM; Kos M; Lipovec NČ; van Vliet E; Alves TL
Vaccine; 2024 Jan; 42(3):556-563. PubMed ID: 38182460
[TBL] [Abstract][Full Text] [Related]
14. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines.
Long B; Bridwell R; Gottlieb M
Am J Emerg Med; 2021 Nov; 49():58-61. PubMed ID: 34062319
[TBL] [Abstract][Full Text] [Related]
15. [Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination].
Kawano H; Hashimoto Y; Hirano T
Rinsho Shinkeigaku; 2021 Sep; 61(9):594-601. PubMed ID: 34373413
[TBL] [Abstract][Full Text] [Related]
16. Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review and Meta-analysis.
Palaiodimou L; Stefanou MI; Katsanos AH; Aguiar de Sousa D; Coutinho JM; Lagiou P; Michopoulos I; Naska A; Giannopoulos S; Vadikolias K; Voumvourakis KI; Papaevangelou V; Vassilakopoulos TI; Tsiodras S; Tsivgoulis G
Neurology; 2021 Nov; 97(21):e2136-e2147. PubMed ID: 34610990
[TBL] [Abstract][Full Text] [Related]
17. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021.
Oliver SE; Wallace M; See I; Mbaeyi S; Godfrey M; Hadler SC; Jatlaoui TC; Twentyman E; Hughes MM; Rao AK; Fiore A; Su JR; Broder KR; Shimabukuro T; Lale A; Shay DK; Markowitz LE; Wharton M; Bell BP; Brooks O; McNally V; Lee GM; Talbot HK; Daley MF
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(3):90-95. PubMed ID: 35051137
[TBL] [Abstract][Full Text] [Related]
18. Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data.
Lane S; Shakir S
Drug Saf; 2022 Sep; 45(9):1003-1008. PubMed ID: 35927605
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Sánchez van Kammen M; Aguiar de Sousa D; Poli S; Cordonnier C; Heldner MR; van de Munckhof A; Krzywicka K; van Haaps T; Ciccone A; Middeldorp S; Levi MM; Kremer Hovinga JA; Silvis S; Hiltunen S; Mansour M; Arauz A; Barboza MA; Field TS; Tsivgoulis G; Nagel S; Lindgren E; Tatlisumak T; Jood K; Putaala J; Ferro JM; Arnold M; Coutinho JM; ; Sharma AR; Elkady A; Negro A; Günther A; Gutschalk A; Schönenberger S; Buture A; Murphy S; Paiva Nunes A; Tiede A; Puthuppallil Philip A; Mengel A; Medina A; Hellström Vogel Å; Tawa A; Aujayeb A; Casolla B; Buck B; Zanferrari C; Garcia-Esperon C; Vayne C; Legault C; Pfrepper C; Tracol C; Soriano C; Guisado-Alonso D; Bougon D; Zimatore DS; Michalski D; Blacquiere D; Johansson E; Cuadrado-Godia E; De Maistre E; Carrera E; Vuillier F; Bonneville F; Giammello F; Bode FJ; Zimmerman J; d'Onofrio F; Grillo F; Cotton F; Caparros F; Puy L; Maier F; Gulli G; Frisullo G; Polkinghorne G; Franchineau G; Cangür H; Katzberg H; Sibon I; Baharoglu I; Brar J; Payen JF; Burrow J; Fernandes J; Schouten J; Althaus K; Garambois K; Derex L; Humbertjean L; Lebrato Hernandez L; Kellermair L; Morin Martin M; Petruzzellis M; Cotelli M; Dubois MC; Carvalho M; Wittstock M; Miranda M; Skjelland M; Bandettini di Poggio M; Scholz MJ; Raposo N; Kahnis R; Kruyt N; Huet O; Sharma P; Candelaresi P; Reiner P; Vieira R; Acampora R; Kern R; Leker R; Coutts S; Bal S; Sharma SS; Susen S; Cox T; Geeraerts T; Gattringer T; Bartsch T; Kleinig TJ; Dizonno V; Arslan Y
JAMA Neurol; 2021 Nov; 78(11):1314-1323. PubMed ID: 34581763
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis.
Hafeez MU; Ikram M; Shafiq Z; Sarfraz A; Sarfraz Z; Jaiswal V; Sarfraz M; Chérrez-Ojeda I
Clin Appl Thromb Hemost; 2021; 27():10760296211048815. PubMed ID: 34698582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
